Taking selective serotonin reuptake inhibitors during pregnancy may not affect an infant's growth during the first year of life, according to a study published online in the American Journal of Psychiatry. Researchers found that babies born to mothers who took the antidepressants had comparable weight, length and head circumference as babies with no exposure to the drugs.
Growth in first year appears unaffected by prenatal SSRI use
SmartBrief Job Listings for Health Care
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|
|Director Account Management||
Samaritan Health Services
|Hospital Medical Device Sales||
Linda Hertz Group